Get news and updates about your favorite shows, plus 3 free credits to watch locked content.

The law change will mean passing background checks becomes a legal ... It is essential that a fair, lawful and transparent system is in place so that decisions are made on evidence not suspicion. ‘ ...

Regeneron (REGN) announced an expansion of its manufacturing capacity through a new agreement with Fujifilm Diosynth Biotechnologies to manufacture and supply bulk drug product of Regeneron’s ...

Cantor Fitzgerald upgraded Regeneron (REGN) to Overweight from Neutral with a price target of $695, down from $800, as the analyst took over coverage of the stock. Published first on TheFly ...